Yuwei Zhang

Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double‐blind, placebo‐controlled, phase 3 trial

G. Qin, Zi-lin Sun, Liujun Fu, 2021, Diabetes, obesity & metabolism.

Expert consensus on personalized initiation of glucose‐lowering therapy in adults with newly diagnosed type 2 diabetes without clinical cardiovascular disease or chronic kidney disease

N. Tong, L. Ji, T. Hong, 2022, Journal of evidence-based medicine.

Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial

P. Li, Liujun Fu, L. Zeng, 2021, Diabetes, obesity & metabolism.

Colloid synthesis of Ni12P5/N, S-doped graphene as efficient bifunctional catalyst for alkaline hydrogen evolution and triiodide reduction reaction.

B. Zhao, Liyan Wang, Tao Zhang, 2023, Journal of colloid and interface science.